Patents by Inventor Emma Louise Blaney

Emma Louise Blaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS
    Publication number: 20230159511
    Abstract: The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
    Type: Application
    Filed: April 22, 2021
    Publication date: May 25, 2023
    Inventors: Cathy Louise Lucas, Emma Louise Blaney, Barrie Phillip Martin, Thorsten Nowak, Nicholas Charles Ray, Simon Ross Crumpler, Eileen Mary Seward, George Hynd
  • THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR
    Publication number: 20200270247
    Abstract: The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Application
    Filed: March 10, 2020
    Publication date: August 27, 2020
    Inventors: Emma Louise Blaney, Barrie Phillip Martin, Thorsten Nowak, Martin John Watson
  • Therapeutic compounds as inhibitors of the orexin-1 receptor
    Patent number: 10611760
    Abstract: The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: April 7, 2020
    Assignee: C4X Discovery Limited
    Inventors: Emma Louise Blaney, Barrie Phillip Martin, Thorsten Nowak, Martin John Watson
  • THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR
    Publication number: 20170291897
    Abstract: The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Application
    Filed: September 3, 2015
    Publication date: October 12, 2017
    Inventors: Emma Louise Blaney, Barrie Phillip Martin, Thorsten Nowak, Martin John Watson
  • ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS
    Publication number: 20100179168
    Abstract: The present invention therefore provides compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) processes for their preparation, pharmaceutical compositions containing the same and to their use in the treatment of gastrointestinal and other disorders.
    Type: Application
    Filed: April 13, 2007
    Publication date: July 15, 2010
    Inventors: Emma Louise Blaney, David Kenneth Dean, Alessandra Gaiba, Nigel Paul King, Jason Witherington